Hanmi Pharmaceutical signs distribution agreement with Laboratorios Sanfer in Mexico

Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735

NewcelX reports positive biomaterial study results supporting stem cell islet delivery without immune suppression

Sanofi's Teizeild approved in EU to delay stage 3 type 1 diabetes

Renalytix expands US clinical footprint with three kidneyintelX.dkd integrations

GSK wins European Commission approval for Shingrix prefilled syringe

Abbott launches Libre Assist for in-the-moment food decisions

RedHill advances RHB-102 across GI indications

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe

Diamyd Medical agrees accelerated efficacy readout in ongoing Phase 3 type 1 diabetes trial

Clywedog Therapeutics activates all clinical centres and patient dosing in balomenib Phase 1b study

Qlife's Egoo Health platform selected for major AI-driven diabetes and MASLD project in China

ALR Technologies announces GluCurve Pet CGM relaunch in Canada

Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide